Hikma Hikes Generics Guidance As It Prepares For New CEO

Also Picks Up US Injectables Assets From Akorn In The Wake Of Bankruptcy

Businessman drawing graph upwards
Hikma is improving its expectations for its generics business • Source: Shutterstock

More from Earnings

More from Business